Literature DB >> 24324994

Access to treatment for breast cancer-related lymphoedema in Australia.

Robyn Sierla1, Deborah Black, Teresa Sze Mun Lee, Sharon Kilbreath.   

Abstract

BACKGROUND: The aim of this study was to describe availability of treatment for lymphoedema in Australia to enable physicians to manage patients with lymphoedema.
METHODS: A validated questionnaire was sent to the Review and Survey Group of the Breast Cancer Network of Australia in May 2010 (n = 760) to investigate consumers' perspectives on treatment access.
RESULTS: Responses were received from 444 women (58%) of whom 140 had received lymphoedema treatment in the previous 5 years. Barriers were encountered by 33% (n = 46). These barriers included access to a lymphoedema therapist (n = 34), treatment affordability (n = 27), need to travel to access treatment (n = 21) and not knowing where to find help (n = 20). DISCUSSION: One-third of this group of women had difficulty accessing treatment to halt this potentially progressive condition. The general practitioner has an important role in detecting this condition, and advising where treatment can be accessed and which schemes might assist financially.

Entities:  

Mesh:

Year:  2013        PMID: 24324994

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  2 in total

1.  Use of compression garments by women with lymphoedema secondary to breast cancer treatment.

Authors:  E Longhurst; E S Dylke; S L Kilbreath
Journal:  Support Care Cancer       Date:  2018-02-19       Impact factor: 3.603

2.  LIMPRINT Study: The Turkish Experience.

Authors:  Pinar Borman; Christine Moffatt; Susie Murray; Aysegul Yaman; Merve Denizli; Meltem Dalyan; Sibel Unsal-Delialioğlu; Sibel Eyigör; Figen Ayhan; Burcu Duyur Çakıt; Secil Vural; Oya Özdemir; Eda Kurt; Evrim Coşkun Çelik; Lale Cerrahoğlu; Müge Kepekçi; Fusun Terzioğlu; Ayşe Arikan Donmez
Journal:  Lymphat Res Biol       Date:  2019-04       Impact factor: 2.589

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.